<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01534676</url>
  </required_header>
  <id_info>
    <org_study_id>AAAI1111</org_study_id>
    <secondary_id>R01HL098014</secondary_id>
    <nct_id>NCT01534676</nct_id>
  </id_info>
  <brief_title>Effects of Transfusion of Older Stored Red Cells</brief_title>
  <official_title>Harmful Effects of Transfusion of Older Stored Red Cells: Iron and Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of transfusion of fresh and stored
      blood on patients.

      The investigators hope to test:

        -  whether a similar effect (older stored blood is associated with worse outcomes) is seen
           in chronically transfused patients with hemoglobinopathies. This patient population will
           also allow the investigators to test whether iron- chelation therapy is beneficial in
           this setting.

        -  whether washing or cryopreserving the red blood cells has any effect on this outcome.

      These findings may explain the immunomodulatory effects of older stored blood in patients and
      will help us develop safer transfusion products for patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiologic studies suggest that older stored blood is associated with worse outcomes in
      certain hospitalized patients. Storage of red cells is associated with a storage lesion and
      the survival of transfused red cells decreases with increasing storage time, thus older blood
      is associated with an increased acute delivery of hemoglobin-iron to the reticuloendothelial
      system. The investigators have preliminary data in healthy human volunteers suggesting that
      delivery of a significant iron load to the reticuloendothelial system from aged red cells
      leads to the elaboration of a potentially toxic form of iron known as non-transferrin-bound
      iron.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty recruiting donors and recipients, looking for alternative sites
  </why_stopped>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-transferrin-bound Iron Level</measure>
    <time_frame>2 hours after transfusion</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Sickle Cell Disease</condition>
  <condition>Thalassemia</condition>
  <arm_group>
    <arm_group_label>Transfusion of Fresh blood</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The recipient will receive one or two units of fresh blood &lt;14 days old, as per their chronic transfusion schedule - on or off chelation therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transfusion of Stored blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The recipient will receive one or two units of old blood &gt;28 days old, as per their chronic transfusion schedule - on or off chelation therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transfusion of Cryopreserved Blood</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The recipient will receive one or two units of cryopreserved (fresh/old) blood, as per their chronic transfusion schedule - off chelation therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transfusion of Washed Blood</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The recipient will receive one or two units of washed (fresh/old) stored blood &gt;28 days old, as per their chronic transfusion schedule - off chelation therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transfusion</intervention_name>
    <description>A routine medical procedure to transfuse packed red blood cells.</description>
    <arm_group_label>Transfusion of Fresh blood</arm_group_label>
    <arm_group_label>Transfusion of Stored blood</arm_group_label>
    <arm_group_label>Transfusion of Cryopreserved Blood</arm_group_label>
    <arm_group_label>Transfusion of Washed Blood</arm_group_label>
    <other_name>RBC transfusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood</intervention_name>
    <description>Processing of RBC for transfusion include the following:
Fresh
Stored
Washed
Frozen (Cryopreserved)</description>
    <arm_group_label>Transfusion of Fresh blood</arm_group_label>
    <arm_group_label>Transfusion of Stored blood</arm_group_label>
    <arm_group_label>Transfusion of Cryopreserved Blood</arm_group_label>
    <arm_group_label>Transfusion of Washed Blood</arm_group_label>
    <other_name>RBC product</other_name>
    <other_name>Reb Blood Cells</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chelation therapy</intervention_name>
    <description>(non-experimental) A medical procedure that involves the administration of chelating agents to remove heavy metals from the body.</description>
    <arm_group_label>Transfusion of Fresh blood</arm_group_label>
    <arm_group_label>Transfusion of Stored blood</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Recipient):

          -  specific, well-characterized hemoglobinopathy

          -  chronic simple transfusion therapy (transfusion episodes &lt; 6 weeks apart in frequency)

          -  chronic iron chelation therapy

          -  not pregnant by self-report and not planning pregnancy

          -  age &gt; 1 year old

        Exclusion Criteria (Recipient):

          -  clinically unstable

          -  treatment for mental illness

          -  imprisonment

          -  institutionalization

        Inclusion Criteria (Donor):

          -  21-65 years of age

          -  male weight &gt; 130 lbs, female weight &gt; 150 lbs

          -  male height &gt; 5'1&quot;, female height &gt; 5'5&quot;

          -  hemoglobin &gt; 15.0 g/dL

          -  reasonably certain of intention to stay in New York City metropolitan area for study
             duration

          -  previously tolerated red blood cell donation

        Exclusion Criteria (Donor):

          -  ineligible for donation based on New York Blood Center blood donor screening
             questionnaire

          -  systolic blood pressure &lt; 90 or &gt; 180 mm Hg, diastolic blood pressure &lt; 50 or &gt; 100 mm
             Hg

          -  heart rate &lt; 50 or &gt; 100

          -  temperature &gt; 99.5 F prior to donation

          -  positive by standard infectious disease testing performed on blood donors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Spitalnik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2012</study_first_submitted>
  <study_first_submitted_qc>February 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2012</study_first_posted>
  <results_first_submitted>August 11, 2016</results_first_submitted>
  <results_first_submitted_qc>August 11, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 5, 2016</results_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Steven L. Spitalnik</investigator_full_name>
    <investigator_title>Professor of Pathology and Cell Biology</investigator_title>
  </responsible_party>
  <keyword>iron</keyword>
  <keyword>transfusion</keyword>
  <keyword>red blood cells</keyword>
  <keyword>sickle cell disease</keyword>
  <keyword>thalassemia</keyword>
  <keyword>blood donors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
    <mesh_term>Thalassemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This is a research study carried out at Columbia University Medical Center. Participants with a blood disorder and currently receive blood transfusions as treatment will be transfused fresh, stored, washed or frozen blood according to regular schedule for up to 3 years. Volunteer dedicated donors will also be asked to provide consent.</recruitment_details>
      <pre_assignment_details>Enrolled participants (recipients) were never randomized or received transfusion on study because study closed due to poor enrollment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Recipients</title>
          <description>Participants with a blood disorder (either sickle cell disease or thalassemia) and currently receive blood transfusions as treatment - will be receiving the following transfusion according to regular schedule: a fresh blood, a stored blood, a washed blood, and a frozen blood transfusion.</description>
        </group>
        <group group_id="P2">
          <title>Donors</title>
          <description>Volunteer dedicated donors will be recruited to donate blood for each transfusion events over the next 3 years. Each patient with a chronic illness such as sickle cell disease or thalassemia will have one dedicated donor.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study closed due to poor enrollment</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Recipients</title>
          <description>Participants with a blood disorder (either sickle cell disease or thalassemia) and currently receive blood transfusions as treatment - will be receiving the following transfusion according to regular schedule: a fresh blood, a stored blood, a washed blood, and a frozen blood transfusion.</description>
        </group>
        <group group_id="B2">
          <title>Donors</title>
          <description>Volunteer dedicated donors will be recruited to donate blood for each transfusion events over the next 3 years. Each patient with a chronic illness such as sickle cell disease or thalassemia will have one dedicated donor.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Non-transferrin-bound Iron Level</title>
        <time_frame>2 hours after transfusion</time_frame>
        <population>Enrolled participants (recipients) were never randomized or received transfusion on study because study closed due to poor enrollment. No data was collected or analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Recipients</title>
            <description>Participants with a blood disorder (either sickle cell disease or thalassemia) and currently receive blood transfusions as treatment - will be receiving the following transfusion according to regular schedule: a fresh blood, a stored blood, a washed blood, and a frozen blood transfusion.</description>
          </group>
          <group group_id="O2">
            <title>Donors</title>
            <description>Volunteer dedicated donors will be recruited to donate blood for each transfusion events over the next 3 years. Each patient with a chronic illness such as sickle cell disease or thalassemia will have one dedicated donor.</description>
          </group>
        </group_list>
        <measure>
          <title>Non-transferrin-bound Iron Level</title>
          <population>Enrolled participants (recipients) were never randomized or received transfusion on study because study closed due to poor enrollment. No data was collected or analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Recipients</title>
          <description>Participants with a blood disorder (either sickle cell disease or thalassemia) and currently receive blood transfusions as treatment - will be receiving the following transfusion according to regular schedule: a fresh blood, a stored blood, a washed blood, and a frozen blood transfusion.</description>
        </group>
        <group group_id="E2">
          <title>Donors</title>
          <description>Volunteer dedicated donors will be recruited to donate blood for each transfusion events over the next 3 years. Each patient with a chronic illness such as sickle cell disease or thalassemia will have one dedicated donor.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Eldad Hod, MD</name_or_title>
      <organization>Columbia University Medical Center</organization>
      <phone>212-342-5648</phone>
      <email>eh2217@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

